Literature DB >> 11870380

Time-dependent Cox regression model is superior in prediction of prognosis in primary sclerosing cholangitis.

Kirsten Muri Boberg1, Giuseppe Rocca, Thore Egeland, Annika Bergquist, Ulrika Broomé, Llorenc Caballeria, Roger Chapman, Rolf Hultcrantz, Stephen Mitchell, Albert Pares, Floriano Rosina, Erik Schrumpf.   

Abstract

More precise prognostic models are needed for prediction of survival in patients with primary sclerosing cholangitis (PSC), particularly for the selection of candidates for liver transplantation. The aim of this study was to develop a time-dependent prognostic model for the calculation of updated short-term survival probability in PSC. Consecutive clinical and laboratory follow-up data from the time of diagnosis were collected from the files of 330 PSC patients from 5 European centers, followed for a median of 8.4 years since diagnosis. Time-fixed and time-dependent Cox regression analyses, as well as the additive regression model, were applied. The reliability of the models was tested by a cross-validation procedure. Bilirubin (on a logarithmic scale), albumin, and age at diagnosis of PSC were identified as independent prognostic factors in multivariate analysis of both the time-fixed and the time-dependent Cox regression models. The importance of bilirubin was more pronounced in the time-dependent model (hazard ratio [HR], 2.84) than in the time-fixed analysis (hazard ratio, 1.51). The additive regression model indicated that once the patients survive beyond the first 5 years, the impact on prognosis of albumin at diagnosis ceases. The time-dependent prognostic model was superior to the time-fixed variant in assigning low 1-year survival probabilities to patients that actually survived less than 1 year. In conclusion, a time-dependent Cox regression model has the potential to estimate a more precise short-term prognosis in PSC compared with the traditional time-fixed models.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11870380     DOI: 10.1053/jhep.2002.31872

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  12 in total

Review 1.  Guideline review: British Society of Gastroenterology/UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis.

Authors:  Alberto Nicoletti; James B Maurice; Douglas Thorburn
Journal:  Frontline Gastroenterol       Date:  2020-03-02

Review 2.  Ursodeoxycholic acid treatment of vanishing bile duct syndromes.

Authors:  Thomas Pusl; Ulrich Beuers
Journal:  World J Gastroenterol       Date:  2006-06-14       Impact factor: 5.742

Review 3.  Primary sclerosing cholangitis: overview and update.

Authors:  Flavia Mendes; Keith D Lindor
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10-12       Impact factor: 46.802

Review 4.  Primary sclerosing cholangitis.

Authors:  Marina G Silveira; Keith D Lindor
Journal:  Can J Gastroenterol       Date:  2008-08       Impact factor: 3.522

5.  Changes in survival patterns in urban Chinese patients with liver cancer.

Authors:  Xi-Shan Hao; Ke-Xin Chen; Peizhong Peter Wang; Tom Rohan
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

6.  Factors associated with major radiological progression of primary sclerosing cholangitis in patients with inflammatory bowel disease.

Authors:  Nahla Azzam; Yazed AlRuthia; Othman Alharbi; Abdulrahman Aljebreen; Majid Almadi; Edward V Loftus
Journal:  Hepatol Int       Date:  2020-12-28       Impact factor: 6.047

7.  Diagnosis of Primary Sclerosing Cholangitis Beyond Childhood is Associated with Worse Outcomes.

Authors:  Stefani Tica; Saad Alghamdi; Christopher Tait; Bonsa Nemera; Yumirle Turmelle; Jaquelyn Fleckenstein; Janis Stoll; Sakil Kulkarni
Journal:  J Clin Exp Hepatol       Date:  2021-03-26

8.  The Sclerosing Cholangitis Outcomes in Pediatrics (SCOPE) Index: A Prognostic Tool for Children.

Authors:  Mark R Deneau; Cara Mack; Emily R Perito; Amanda Ricciuto; Pamela L Valentino; Mansi Amin; Achiya Z Amir; Madeleine Aumar; Marcus Auth; Annemarie Broderick; Matthew DiGuglielmo; Laura G Draijer; Eleonora Druve Tavares Fagundes; Wael El-Matary; Federica Ferrari; Katryn N Furuya; Nitika Gupta; Jessica T Hochberg; Matjaz Homan; Simon Horslen; Raffaele Iorio; M Kyle Jensen; Maureen M Jonas; Binita M Kamath; Nanda Kerkar; Kyung Mo Kim; Kaija-Leena Kolho; Bart G P Koot; Trevor J Laborda; Christine K Lee; Kathleen M Loomes; Mercedes Martinez; Alexander Miethke; Tamir Miloh; Douglas Mogul; Saeed Mohammad; Parvathi Mohan; Stacy Moroz; Nadia Ovchinsky; Sirish Palle; Alexandra Papadopoulou; Girish Rao; Alexandre Rodrigues Ferreira; Pushpa Sathya; Kathleen B Schwarz; Uzma Shah; Eyal Shteyer; Ruchi Singh; Vratislav Smolka; Nisreen Soufi; Atsushi Tanaka; Raghu Varier; Bernadette Vitola; Marek Woynarowski; Melissa Zerofsky; Andréanne Zizzo; Stephen L Guthery
Journal:  Hepatology       Date:  2020-12-19       Impact factor: 17.425

9.  Indications and Outcomes in Liver Transplantation in Patients With Primary Sclerosing Cholangitis in Norway.

Authors:  Ina M Andersen; Bjarte Fosby; Kirsten M Boberg; Ole P F Clausen; Peter Jebsen; Espen Melum; Pål D Line; Aksel Foss; Erik Schrumpf; Tom H Karlsen
Journal:  Transplant Direct       Date:  2015-10-19

Review 10.  Harnessing repeated measurements of predictor variables for clinical risk prediction: a review of existing methods.

Authors:  Lucy M Bull; Mark Lunt; Glen P Martin; Kimme Hyrich; Jamie C Sergeant
Journal:  Diagn Progn Res       Date:  2020-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.